Becton Dickinson Acquire GenCell Biosystems


BD Becton, Dickinson and Company NYSE: BDX, a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing NGS to genotyping for agricultural applications.

For further details click here.